Results 121 to 130 of about 85,339 (226)
Lymphatic Endothelial Cells in Health and Disease
Lymphatic endothelial cells (LECs) are dynamic regulators of tissue homeostasis and disease remodeling. In the healthy state, LECs coordinate interstitial fluid drainage, intestinal lipid transport, and immune trafficking and tolerance. Across disease settings, however, these same programs become maladaptively reprogrammed, contributing to barrier ...
Du Tang +5 more
wiley +1 more source
Mixed Medullary and Papillary Thyroid Carcinoma in a Patient on Tirzepatide. [PDF]
Beshay LH, Makker J, Ahern S.
europepmc +1 more source
23Na‐MRI at 3 T was applied to estimate TSC in patients with kidney tumours of different pathologies, which are indistinguishable on conventional imaging methods. The apparent TSC was significantly higher in renal oncocytomas (benign) compared to chromophobe renal cell carcinomas (malignant): 162 ± 58 mM vs. 71 ± 2 mM (p < 0.05).
Ines Horvat‐Menih +16 more
wiley +1 more source
Coexistence of medullary and papillary thyroid carcinoma in the same lobe-isthmus complex: A case report. [PDF]
Murali G +5 more
europepmc +1 more source
The Role of Thyroidectomy in the Management of Thyroglossal Duct Carcinoma: A Systematic Review
Abstract Objective The extent of surgical management of thyroglossal duct‐associated differentiated thyroid carcinoma remains controversial. This study aims to evaluate the role of total thyroidectomy in patients with thyroglossal duct‐associated differentiated thyroid carcinoma and provide insights to support individualized, evidence‐based care.
Hidde H. IJtsma +6 more
wiley +1 more source
Analysis of the concurrent occurrence of medullary thyroid carcinoma and papillary thyroid carcinoma: A dual center, retrospective study in China. [PDF]
Qi X, Ni Z, Hong L, Ding J, Zhou T.
europepmc +1 more source
ABSTRACT Aim This study aimed to evaluate its safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy in Chinese adults with T2DM and to preliminarily compare its efficacy and safety with semaglutide through multiple subcutaneous injections. Materials and Methods In this multicentre, randomised, placebo‐controlled and semaglutide‐positive‐
Ping Jin +9 more
wiley +1 more source
Glucagon-like peptide-1 receptor (GLP-1R) overexpression defines a distinct immunogenetic subset in primary and metastatic thyroid cancer: implications for GLP-1R agonist therapy. [PDF]
Kennedy S +11 more
europepmc +1 more source
ABSTRACT Aims There is an unmet need for effective pharmacotherapy for obesity disease management in Japan. Survodutide is a novel glucagon receptor/glucagon‐like peptide‐1 receptor (GLP‐1R) dual agonist with the potential to induce greater weight reductions than GLP‐1R mono‐agonists. We report the design and baseline participant characteristics of the
Koutaro Yokote +10 more
wiley +1 more source
ABSTRACT Aim To evaluate the efficacy, safety and immunogenicity of semaglutide injection (synthetic) (Test group) compared with the Reference semaglutide injection [Ozempic, (Reference group)] in Indian patients with Type 2 diabetes mellitus (T2DM).
Unnikrishnan Ambika Gopalakrishnan +33 more
wiley +1 more source

